Prasugrel

Type: Product
Name: Prasugrel
First reported Oct 17 2014 - Updated Oct 18 2014 - 1 reports

Selecting Antiplatelet Agents for Diabetics With Acute Coronary Syndrome

Jeannette Y. Wick, RPh, MBA, FASCPPatients with acute coronary syndrome (ACS) rely on platelet P2Y 12 -receptor antagonists and aspirin to reduce the risk of serious adverse cardiovascular events. While the current American College of Cardiology Foundation/American ... [Published Pharmacy Times - Oct 17 2014]
First reported Oct 13 2014 - Updated Oct 13 2014 - 1 reports

Antithrombotics in ACS and TAVR

ATLANTIC: Did Fast Ambulances Erase Benefit?Neil E. Moat, MBBS, FRCS: Welcome to the European Society of Cardiology (ESC) Congress in Barcelona. I am Neil Moat. I'm a cardiac surgeon from London, in England. It's a pleasure to be joined by Michelle O'Donoghue, ... [Published Theheart.org - Oct 13 2014]
First reported Oct 13 2014 - Updated Oct 13 2014 - 1 reports

Prasugrel Plus Bivalirudin vs Clopidogrel Plus Heparin STEMI

Task Force on the management of STseamiotESoC, Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti ... [Published Theheart.org - Oct 13 2014]
First reported Oct 10 2014 - Updated Oct 10 2014 - 1 reports

Platelet Function Inhibitors in Neurointerventional Procedures

Lee DH, Arat A, Morsi H, et al . Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: a single-center experience. AJNR Am J Neuroradiol 2008;29:1389–94.Drazin D, Choulakian A, Nuno M, et ... [Published General Medicine eJournal - Oct 10 2014]
First reported Oct 06 2014 - Updated Oct 06 2014 - 6 reports

Brilinta preferred over clopidogrel in latest AHA/ACC guideline

Anglo-Swedish pharma major AstraZeneca (LSE: AZN) today confirmed that the American Heart Association (AHA) and American College of Cardiology (ACC) have updated the guideline for the management of patients with non–ST-elevation acute coronary syndromes ... [Published Pharma Letter - Oct 06 2014]
First reported Oct 03 2014 - Updated Oct 03 2014 - 1 reports

Dr Le Fanu's online health clinic, Friday 3rd October 2014

Concerned about aches and pains? Worried about a medical condition? You can email your questions confidentially to Dr Le Fanu at drjames@telegraph.co.uk. Answers will be published in the health section of the Telegraph website every Friday. Today - itching ... [Published Telegraph - Oct 03 2014]
Entities: NHS, Plantago, Scrotum
First reported Sep 30 2014 - Updated Sep 30 2014 - 1 reports

EFFIENT (Prasugrel Hydrochloride) Tablet, Film Coated [Cardinal Health]

First reported Sep 25 2014 - Updated Sep 25 2014 - 1 reports

Patent Issued for Pharmaceutical Compositions Comprising Prasugrel and Cyclodextrin Derivatives and Methods of Making and Using the Same

By a News Reporter-Staff News Editor at Biotech Week -- CyDex Pharmaceuticals, Inc. (La Jolla, CA) has been issued patent number 8835407, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors (see also CyDex Pharmaceuticals, ... [Published Wall Street Business Network - Sep 25 2014]
First reported Sep 24 2014 - Updated Sep 24 2014 - 1 reports

Effient (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Research and Markets (http://www.researchandmarkets.com/research/z9p4lm/effient_acute) has announced the addition of the "" report to their offering. Effient is an antiplatelet blood thinner that inhibits the P2Y12 receptor. Inhibition of P2Y12 blocks ... [Published Individual.com - Sep 24 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

TRANSLATE-ACS: No MACE Benefit With Prasugrel in ACS

WASHINGTON, DC — A real-world comparison of clopidogrel vs prasugrel (Effient, Lilly/Daiichi-Sankyo) in nearly 12 000 acute coronary syndrome (ACS) patients undergoing PCI revealed no significant differences in the rate of major adverse cardiovascular ... [Published American Journal of Public Health - Sep 18 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same

The present invention is directed to pharmaceutical compositions comprising prasugrel and a cyclodextrin derivative, and methods of making and using the same. ... [Published Free Patents Online - Sep 16 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

EFFIENT (Prasugrel Hydrochloride) Tablet, Film Coated [Eli Lilly And Company ]

Quotes

...Ridong Chen. "We look forward to working together with partners to complete preclinical safety studies and progress to clinical trials so that this unique therapy will eventually make a difference for patients."
"There has definitely been more uptake of these more potent antiplatelet therapies," added Wang. "In the US, a lot of it is driven by socioeconomic factors"
Original Article: NEXT ARTICLE More From BioPortfolio on "Heart patients in England and Wales offered more choice of therapies as NICE extends recommendations for prasugrel"

More Content

All (34) | News (26) | Reports (0) | Blogs (8) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Selecting Antiplatelet Agents for Diabetics Wit... [Published Pharmacy Times - Oct 17 2014]
Antithrombotics in ACS and TAVR [Published Theheart.org - Oct 13 2014]
Prasugrel Plus Bivalirudin vs Clopidogrel Plus ... [Published Theheart.org - Oct 13 2014]
Platelet Function Inhibitors in Neurointerventi... [Published General Medicine eJournal - Oct 10 2014]
APT Therapeutics Updates on Apyrase-Based Inves... [Published Individual.com - Oct 07 2014]
Brilinta preferred over clopidogrel in latest A... [Published Pharma Letter - Oct 06 2014]
BRILINTA Preferred Over Clopidogrel in 2014 AHA... [Published Investor's Business Daily - Oct 06 2014]
BRILINTA Preferred Over Clopidogrel in 2014 AHA... [Published EON: Enhanced Online News - Oct 06 2014]
BRILINTA Preferred Over Clopidogrel in 2014 AHA... [Published EON Science - Oct 06 2014]
BRILINTA Preferred Over Clopidogrel in 2014 AHA... [Published Business Wire Science: Science News - Oct 06 2014]
BRILINTA Preferred Over Clopidogrel in 2014 AHA... [Published Business Wire Health News - Oct 06 2014]
Dr Le Fanu's online health clinic, Friday 3rd O... [Published Telegraph - Oct 03 2014]
APT Therapeutics’ Apyrase-Based Investigational... [Published Town Hall - Oct 02 2014]
PharmaPoint: Acute Coronary Syndrome - 5EU Drug... [Published Individual.com - Oct 02 2014]
EFFIENT (Prasugrel Hydrochloride) Tablet, Film ... [Published DailyMed Drug Label Updates for the last seven ... - Sep 30 2014]
Patent Issued for Pharmaceutical Compositions C... [Published Wall Street Business Network - Sep 25 2014]
Effient (Acute Coronary Syndrome) - Forecast an... [Published Individual.com - Sep 24 2014]
PharmaPoint: Acute Coronary Syndrome - Japan Dr... [Published Individual.com - Sep 24 2014]
TRANSLATE-ACS: No MACE Benefit With Prasugrel i... [Published American Journal of Public Health - Sep 18 2014]
Pharmaceutical compositions comprising prasugre... [Published Free Patents Online - Sep 16 2014]
Long-term Dual-Antiplatelet Treatment After DES... [Published General Medicine eJournal - Sep 16 2014]
TCT.14: Heparin may come back in vogue, but in ... [Published Cardiovascular Business - Sep 15 2014]
Ticagrelor vs Clopidogrel in Non-ST-Elevation ACS [Published Theheart.org - Sep 11 2014]
EFFIENT (Prasugrel Hydrochloride) Tablet, Film ... [Published DailyMed Drug Label Updates for the last seven ... - Aug 12 2014]
Heart patients in England and Wales offered mor... [Published BioPortfolio - Jul 24 2014]
NICE recommends drugs for blood clots and const... [Published BioPortfolio - Jul 24 2014]
Daiichi Sankyo and Eli Lilly and Company: Heart... [Published Business Wire Health News - Jul 23 2014]
Industry up in arms against NPPA for bringing 1... [Published PharmaBiz - Jul 15 2014]
Court Report [Published Patent Docs - Jul 07 2014]
Net earnings of 5 leading Japanese pharma compa... [Published PharmaBiz - Jul 04 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
BRILINTA Preferred Over Clopidogrel in 2014 AHA... [Published EON Science - Oct 06 2014]
WILMINGTON, Del.--(EON: Enhanced Online News)--AstraZeneca (NYSE:AZN) today confirmed that the American Heart Association (AHA) and American College of Cardiology (ACC) have updated the guideline for the management of patients with non–ST-elevation acute ...
BRILINTA Preferred Over Clopidogrel in 2014 AHA... [Published Business Wire Science: Science News - Oct 06 2014]
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE:AZN) today confirmed that the American Heart Association (AHA) and American College of Cardiology (ACC) have updated the guideline for the management of patients with non–ST-elevation acute coronary ...
BRILINTA Preferred Over Clopidogrel in 2014 AHA... [Published Business Wire Health News - Oct 06 2014]
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE:AZN) today confirmed that the American Heart Association (AHA) and American College of Cardiology (ACC) have updated the guideline for the management of patients with non–ST-elevation acute coronary ...
EFFIENT (Prasugrel Hydrochloride) Tablet, Film ... [Published DailyMed Drug Label Updates for the last seven ... - Sep 30 2014]
Updated Date: Sep 30, 2014 EST ...
EFFIENT (Prasugrel Hydrochloride) Tablet, Film ... [Published DailyMed Drug Label Updates for the last seven ... - Aug 12 2014]
Updated Date: Aug 12, 2014 EST ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.